Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus

The Journal of Clinical Investigation
R L RairighS H Abman

Abstract

Nitric oxide (NO) produced by NO synthase (NOS) modulates fetal pulmonary vascular tone and contributes to the fall in pulmonary vascular resistance (PVR) at birth. Although the inducible (type II) NOS isoform is present in human and rat fetal lungs, it is uncertain whether type II NOS activity contributes to vascular NO production in the fetal lung. To determine whether type II NOS is present in the ovine fetal lung and to study the potential contribution of type II NOS on the regulation of basal PVR in the fetus, we measured the hemodynamic effects of three selective type II NOS antagonists: aminoguanidine (AG), 2-amino-5,6-dihydro-6-methyl-4H-1,3 thiazine (AMT), and S-ethylisothiourea (EIT). Studies were performed after at least 72 h of recovery from surgery in 19 chronically prepared fetal lambs (133+/-3 d; 147 d, term). Brief intrapulmonary infusions of AG (140 mg), AMT (0.12 mg), and EIT (0.12 mg) increased basal PVR by 82, 69, and 77%, respectively (P < 0.05). The maximum increase in PVR occurred within 20 min, but often persisted up to 80 min. These agents also increased mean aortic pressure but did not alter the pressure gradient between the pulmonary artery and aorta, suggesting little effect on tone of the ductus art...Continue Reading

References

Oct 1, 1976·Circulation Research·A B LewisA M Rudolph
Nov 15, 1990·Biochemical and Biophysical Research Communications·R G KilbournR F Lodato
Nov 15, 1993·Biochemical and Biophysical Research Communications·S LiuT W Evans
Nov 1, 1993·British Journal of Pharmacology·M J GriffithsT W Evans
Apr 1, 1994·Kidney International·A JansenV Cattell
May 1, 1995·Canadian Journal of Physiology and Pharmacology·W R TraceyG Carter
Oct 1, 1993·American Journal of Respiratory Cell and Molecular Biology·L KobzikJ S Stamler
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A CorbettE R Unanue
Jun 1, 1994·The Journal of Clinical Investigation·J R FinemanS J Soifer
Oct 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·U Förstermann, H Kleinert
Sep 1, 1995·Clinical and Experimental Pharmacology & Physiology·M H YenC C Wu
Feb 23, 1996·Biochemical Pharmacology·G J Southan, C Szabó
Mar 15, 1997·The Journal of Clinical Investigation·D D IvyS H Abman

❮ Previous
Next ❯

Citations

Sep 4, 2012·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Mirosława KoronkiewiczZygmunt Kazimierczuk
Sep 23, 2008·Annals of Biomedical Engineering·Yi HuangGhassan S Kassab
Nov 3, 2001·Journal of the American College of Cardiology·Y IshibashiM Hashimoto
May 6, 1999·American Journal of Respiratory and Critical Care Medicine·M T GladwinF P Ognibene
Feb 23, 2013·International Journal of Molecular Sciences·Monica R ShahKathryn N Farrow
Nov 11, 2008·Journal of Cardiac Failure·Yutaka IshibashiToshio Shimada
Aug 12, 1999·Nitric Oxide : Biology and Chemistry·I AthanassakisS Vassiliadis
Mar 23, 2001·American Journal of Obstetrics and Gynecology·M A AnwarP W Nathanielsz
Nov 1, 2001·Respiratory Research·N S Ghanayem, J B Gordon
May 15, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Charissa RichardJeff Reese
Jun 21, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Philippe DeruelleSteven H Abman
Oct 21, 2010·Physiological Reviews·Yuansheng Gao, J Usha Raj
Apr 12, 2001·British Journal of Haematology·G W Hall
Apr 13, 1999·The American Journal of Physiology·M J Miller, M Sandoval
Mar 10, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·T D Le Cras, I F McMurtry
Jul 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ethan P CarterIvan F McMurtry
Feb 10, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Candice D FikeMark R Kaplowitz
Jan 25, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·R L RairighS H Abman
Feb 10, 1999·The American Journal of Physiology·T S ShermanP W Shaul
Aug 13, 1999·The American Journal of Physiology·M A RuddJ Loscalzo
Jul 31, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C A MasonM Rabinovitch
Dec 21, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Philippe DeruelleSteven H Abman
Jul 12, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·M J MorinP A Gruppuso
Sep 15, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·A N MacRitchieR D Bland
Jan 25, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·T A ParkerS H Abman
Oct 4, 2000·Physiological Reviews·V Hampl, J Herget
Apr 13, 1999·The American Journal of Physiology·M A AnwarP W Nathanielsz
Feb 15, 2003·Sleep Medicine Reviews·Lena Lavie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.